Since AID only expresses in B cells during the GC reaction, we hypothesize that AID plays a role during the clonal development of CLL by suppressing the expression of XBP1s and compromising BCR signaling resulting in the less aggressive phenotypes of IgHV-mutated CLL. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.